These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 715964)

  • 1. Transfer of adoptive immunity by intra-arterial injection of tumor-immune pig lymph node cells: treatment of recurrent urinary bladder carcinoma after radical radiotherapy.
    Symes MO; Mitchell JP; Eckert H; Roberts JB; Feneley RC; Tribe CR; Lai T
    Urology; 1978 Oct; 12(4):398-401. PubMed ID: 715964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive immunotherapy and radiotherapy in the treatment of urinary bladder cancer.
    Symes MO; Eckert H; Feneley RC; Lai T; Mitchell JP; Roberts JB; Tribe CR
    Br J Urol; 1978 Aug; 50(5):328-31. PubMed ID: 753485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of bladder carcinoma with tumor-immune pig lymph node cells. Phase I study.
    Symes MO; Eckert H; Feneley RC; Gingell JC; Lai T; Roberts JB; Smith PJ; Tribe CR
    Urology; 1985 Apr; 25(4):383-5. PubMed ID: 3984127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of immunized pig lymph-node cells in the treatment of patients with advanced malignant disease.
    Symes MO; Riddell AG
    Br J Surg; 1973 Mar; 60(3):176-80. PubMed ID: 4735046
    [No Abstract]   [Full Text] [Related]  

  • 5. Porcine sensitized lymph node cells (immunotherapy) and attenuated irradiation for infiltrative transitional cells carcinoma of bladder.
    Cockett AT; de Sant'agnese PA; Hamlin DJ; Keys HM
    Urology; 1982 Jun; 19(6):593-8. PubMed ID: 7090105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy for non-muscle invasive bladder cancer: HP-NAP].
    D'Agostino D; Racioppi M; Filianoti A; Di Gianfrancesco L; Codolo G; Fassan M; Munari F; Rugge M; D'Elios MM; de Bernard M; Pagano F; Bassi P
    Urologia; 2012; 79(2):142-8. PubMed ID: 22522462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of T-cell-based adoptive immunotherapy in the first 12 patients with advanced urothelial urinary bladder cancer. Preliminary data on a new immunologic treatment based on the sentinel node concept.
    Sherif A; Hasan MN; Marits P; Karlsson M; Winqvist O; Thörn M
    Eur Urol; 2010 Jul; 58(1):105-11. PubMed ID: 19766386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor cells in the pelvic lymph nodes regional to bladder cancer.
    Herr HW
    J Surg Oncol; 1979; 11(4):289-93. PubMed ID: 156288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokine therapy of superficial bladder carcinoma. Mechanisms of action and results of therapy].
    Otto T; Kälble T
    Urologe A; 1994 Nov; 33(6):540-6. PubMed ID: 7817454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.
    Morales A; Eidinger D; Bruce AW
    J Urol; 1976 Aug; 116(2):180-3. PubMed ID: 820877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5-fluorouracil: a phase I study.
    Danesi DT; Arcangeli G; Cruciani E; Mecozzi A; Saracino B; Giacobini S; Pannunzio E; Biggio A; Orefici F
    Cancer; 1997 Oct; 80(8):1464-71. PubMed ID: 9338471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bladder carcinoma treated by irradiation and surgery: interval report.
    Deweerd JH; Colby MY
    Trans Am Assoc Genitourin Surg; 1972; 64():74-8. PubMed ID: 4654525
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trials of immunotherapy in tumors of the urinary tract].
    Corrado F; Pizza G
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():659-66. PubMed ID: 6336141
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed leukocyte culture reactivity of lymph node cells regional to transitional cell carcinoma of the bladder.
    Herr HW; Bean MA; Whitmore WF
    Natl Cancer Inst Monogr; 1978 Dec; (49):177-81. PubMed ID: 155221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response.
    Daro-Faye M; Kassouf W; Souhami L; Marcq G; Cury F; Niazi T; Sargos P
    World J Urol; 2021 May; 39(5):1331-1343. PubMed ID: 32915313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of advanced bladder cancer with sensitized pig lymphocytes.
    Symes MO; Riddell AG; Feneley RC; Tribe CR
    Br J Cancer Suppl; 1973 Aug; 1():276-84. PubMed ID: 4804286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keyhole-limpet haemacyanin and immune ribonucleic acid immunotherapy of murine transitional cell carcinoma.
    Lamm DL; Reyna JA; Reichert DF
    Urol Res; 1981; 9(5):227-30. PubMed ID: 7303346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of radiation-based conservation therapy for invasive bladder cancer.
    Chung PW; Bristow RG; Milosevic MF; Yi QL; Jewett MA; Warde PR; Catton CN; McLean M; Moore M; Tannock IF; Gospodarowicz MK
    Urol Oncol; 2007; 25(4):303-9. PubMed ID: 17628296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.